Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Elokdah Hassan Mahmoud
公开号:US20070244106A1
公开(公告)日:2007-10-18
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。